This compound is primarily utilized in organic synthesis and pharmaceutical research. It serves as a key intermediate in the development of various bioactive molecules, particularly those targeting neurological and cardiovascular disorders. Its structure, featuring a morpholine and cyclohexyl group, makes it valuable for designing compounds with enhanced bioavailability and target specificity. Additionally, it is used in the preparation of proteolysis-targeting chimeras (PROTACs), which are innovative therapeutic agents for degrading disease-causing proteins. Its stability and reactivity also make it suitable for use in peptide coupling reactions and as a building block in medicinal chemistry.